Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of Late SV40 Factor (LSF) as cancer chemotherapeutics

Inhibitors of Late SV40 Factor (LSF) as cancer chemotherapeutics

US Patent 10392398 · Granted Aug 27, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Kinase inhibitors and methods of use thereof2025
Antileishmanial compounds, compositions and use thereof2025
Antileishmanial compounds, compositions and use thereof2025
Quinolin-2(1H)-one inhibitors of Late SV40 Factor2022
Quinolin-2(1H)-one inhibitors of Late SV40 Factor2022
Late SV40 (LSF) inhibitors2022
Late SV40 (LSF) inhibitors2022
Heterocyclic LSF inhibitors and their uses2022
Heterocyclic LSF inhibitors and their uses2022
Heterocyclic LSF inhibitors and their uses2022
Kinase inhibitors and methods of use thereof2021
Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics2019